Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Malhotra

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
The Journal of the Association of Physicians of India|March 1, 1988
Coronary risk factors and ischaemic heart diseaseH Malhotra
Indian Journal of Cancer|December 15, 2012
Janus activated kinase inhibition in myelofibrosisH Malhotra
The Journal of the Association of Physicians of India|April 1, 1994
Survival in chronic myeloid leukemiaH Malhotra
Indian Journal of Cancer|September 15, 2009
Cisplatin ototoxicityH Malhotra
Medical Physics|May 19, 2017
SU-E-J-25: Dosimetric Characterization of an OBI System Using Gafchromic XRQA2 FilmH Malhotra, J Steinman
Drugs & Aging|December 12, 2001
Cisplatin/epinephrine injectable gelH Malhotra, G L Plosker
The Journal of the Association of Physicians of India|October 1, 1990
Pure red cell aplasia and rheumatoid arthritisH Malhotra, S H Advani
The Journal of the Association of Physicians of India|March 1, 1991
Correct terminology in leukaemia treatmentH Malhotra, S H Advani
Comprehensive Psychiatry|January 1, 1977
Fluphenazine therapy in groupsK H Malhotra, S G Olgiati
The Journal of the Association of Physicians of India|July 20, 2002
IgA myeloma presenting as diabetes mellitus with refractory anaemiaSabita Basu, Nidhi Gupta, H Malhotra
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
The Journal of the Association of Physicians of India|March 1, 1988
Coronary risk factors and ischaemic heart diseaseH Malhotra
Indian Journal of Cancer|December 15, 2012
Janus activated kinase inhibition in myelofibrosisH Malhotra
The Journal of the Association of Physicians of India|April 1, 1994
Survival in chronic myeloid leukemiaH Malhotra
Indian Journal of Cancer|September 15, 2009
Cisplatin ototoxicityH Malhotra
Medical Physics|May 19, 2017
SU-E-J-25: Dosimetric Characterization of an OBI System Using Gafchromic XRQA2 FilmH Malhotra, J Steinman
Drugs & Aging|December 12, 2001
Cisplatin/epinephrine injectable gelH Malhotra, G L Plosker
The Journal of the Association of Physicians of India|October 1, 1990
Pure red cell aplasia and rheumatoid arthritisH Malhotra, S H Advani
The Journal of the Association of Physicians of India|March 1, 1991
Correct terminology in leukaemia treatmentH Malhotra, S H Advani
Comprehensive Psychiatry|January 1, 1977
Fluphenazine therapy in groupsK H Malhotra, S G Olgiati
The Journal of the Association of Physicians of India|July 20, 2002
IgA myeloma presenting as diabetes mellitus with refractory anaemiaSabita Basu, Nidhi Gupta, H Malhotra
Pageof 5